Moleac introduces NurAiD II in France
NurAiD II comprises a blend of nine medicinal Chinese herbal extracts. The product is used to stimulate neuroplasticity of healthy tissues, thereby aiding in the recovery of both
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The study published as a research article, ‘Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes’ investigated the details of a novel proteomics based method in detecting inhibition